Funds and ETFs Thermo Fisher Scientific
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
493.81 USD | +0.45% | +0.18% | -10.33% |
ETFs positioned on Thermo Fisher Scientific
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
16.86% | 4,371 M€ | -3.99% | ||
16.72% | 131 M€ | -1.91% | ||
11.69% | 2 M€ | -25.75% | ||
7.43% | 26 M€ | +9.53% | - | |
6.88% | 4 M€ | +4.46% | - | |
5.37% | 2 M€ | 0.00% | ||
5.16% | 132 M€ | -7.45% | - | |
5.16% | 27 M€ | -5.64% | - | |
5.16% | 16 M€ | 0.00% | - | |
5.15% | 1 M€ | -.--% | - | |
5.15% | 50 M€ | -6.77% | - | |
5.15% | 12 M€ | -6.47% | - | |
4.88% | 3 M€ | -14.16% | ||
4.80% | 11 M€ | 0.00% | - | |
4.80% | 820 M€ | -4.99% | - | |
4.80% | 68 M€ | 0.00% | - | |
4.60% | 48 M€ | -4.31% | - | |
4.33% | 105 M€ | -4.49% | - | |
4.33% | 1,872 M€ | -.--% | ||
4.33% | 309 M€ | -1.46% | ||
4.32% | 33,985 M€ | -2.83% | ||
4.32% | 8 M€ | 0.00% | - | |
4.29% | 2 M€ | -3.09% | - | |
4.12% | 2,705 M€ | -2.75% | ||
4.11% | 892 M€ | 0.00% | ||
4.08% | 2 M€ | 0.00% | ||
3.77% | 14,471 M€ | -2.94% | ||
3.65% | 2,626 M€ | -2.99% | ||
3.64% | 89 M€ | -1.53% | ||
3.41% | 66 M€ | +18.71% | - | |
3.28% | 14 M€ | +12.19% | - | |
3.23% | 158 M€ | +21.26% | - | |
3.17% | 91 M€ | +0.35% | ||
3.17% | 5 M€ | +0.70% | - | |
3.10% | 2 M€ | -.--% | - | |
3.05% | 3,600 M€ | -1.35% | ||
3.05% | 746 M€ | +1.47% | - |
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows:
- laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.;
- diagnostics equipment and products (15.3%);
- scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.
Net sales break down by source of income into products sales (78.5%) and services (21.5%).
Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
2023-12-13
- U.S. Currency
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
BUY
Number of Analysts
26
Last Close Price
493.81USD
Average target price
531.22USD
Spread / Average Target
+7.58%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.33% | 191 B $ | |
-16.83% | 163 B $ | |
+16.92% | 109 B $ | |
+18.48% | 80 310 M $ | |
+12.56% | 63 346 M $ | |
-10.80% | 47 620 M $ | |
-6.86% | 42 146 M $ | |
-13.86% | 37 658 M $ | |
+16.56% | 30 979 M $ | |
-21.20% | 24 121 M $ |
- Stock
- Equities
- Stock Thermo Fisher Scientific - Nyse
- Funds and ETFs Thermo Fisher Scientific